Subcutaneous abatacept: long-term data from the ACQUIRE trial

被引：0
|
作者：
Alten, R. [1 ]
Pacheco-Tena, C. [2 ]
Covarrubias-Cobos, J. [3 ]
Leon, G. [4 ]
Mysler, E. [5 ]
Keiserman, M. [6 ]
Valente, R. [7 ]
Nash, P. [8 ]
Simon-Campos, J. [9 ]
Box, J. [10 ]
Legerton, C., III [11 ]
Nasonov, E. [12 ]
Durez, P. [13 ]
Delaet, I. [14 ]
Genovese, M. [15 ]
机构：
[1] Charite, Akad Lehrkrankenhaus, Schlosspk Klin, D-13353 Berlin, Germany
[2] Univ Autonoma Chihuahua, Chihuahua, Mexico
[3] Unidad Reumatol Amer SCP, Merida, Mexico
[4] Inst Ginecol & Reprod, Lima, Peru
[5] Org Med Invest, Buenos Aires, DF, Argentina
[6] Pontificial Catholic Univ Sch Med, Porto Alegre, RS, Brazil
[7] Phys Res Collaborat, Lincoln, NE USA
[8] Univ Queensland, Brisbane, Qld, Australia
[9] Univ Marista, Ctr Especialidades Med, Merida, Mexico
[10] Box Arthrit & Rheumatol Carolinas, Charlotte, NC USA
[11] Low Country Rheumatol, Charleston, SC USA
[12] Russian Acad Med Sci, Inst Rheumatol, Moscow 109801, Russia
[13] Catholic Univ Louvain, B-1200 Brussels, Belgium
[14] Bristol Myers Squibb Co, Princeton, NJ USA
[15] Stanford Univ, Palo Alto, CA 94304 USA
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：118 / 118
页数：1
相关论文
共 50 条
  • [1] Subcutaneous Abatacept: Long-Term Data From the Acquire Trial
    Genovese, M. C.
    Pacheco-Tena, C.
    Covarrubias, A.
    Leon, G.
    Mysler, E.
    Keiserman, M.
    Valente, R.
    Nash, P.
    Simon-Campos, J. A.
    Box, J.
    Legerton, C., III
    Nasonov, E.
    Durez, P.
    Delaet, I.
    Alten, R.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S201 - S201
  • [2] SUBCUTANEOUS ABATACEPT: LONG-TERM DATA FROM THE ACQUIRE TRIAL
    Alten, R.
    Pacheco-Tena, C.
    Covarrubias, A.
    Leon, G.
    Mysler, E.
    Keiserman, M.
    Valente, R.
    Nash, P.
    Simon-Campos, J.
    Box, J.
    Legerton, C., III
    Nasonov, E.
    Durez, P.
    Delaet, I.
    Genovese, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 248 - 248
  • [3] SUBCUTANEOUS ABATACEPT VERSUS INTRAVENOUS ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS: LONG-TERM DATA FROM THE ACQUIRE TRIAL
    Genovese, Mark C.
    Covarrubias Cobos, Arturo
    Leon, Gustavo
    Mysler, Eduardo F.
    Keiserman, Mauro W.
    Valente, Robert M.
    Nash, Peter T.
    Simon Campos, J. Abraham
    Porawska, Wieslawa
    Box, Jane H.
    Legerton, Clarence W., III
    Nasonov, Evgeny L.
    Durez, Patrick
    Pappu, Ramesh
    Delaet, Ingrid
    Teng, Julie
    Alten, Rieke
    [J]. RHEUMATOLOGY, 2012, 51 : 128 - 129
  • [4] Subcutaneous Abatacept for the Treatment of Rheumatoid Arthritis: Longterm Data from the ACQUIRE Trial
    Genovese, Mark C.
    Pacheco Tena, Cesar
    Covarrubias, Arturo
    Leon, Gustavo
    Mysler, Eduardo
    Keiserman, Mauro
    Valente, Robert
    Nash, Peter
    Abraham Simon-Campos, J.
    Box, Jane
    Legerton, Clarence William, III
    Nasonov, Evgeny
    Durez, Patrick
    Delaet, Ingrid
    Teng, Julie
    Alten, Rieke
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (04) : 629 - 639
  • [5] Subcutaneous (SC) Abatacept (ABA) Versus Intravenous (IV) ABA in Patients (pts) with Rheumatoid Arthritis: Long-Term Data From the ACQUIRE (Abatacept Comparison of Sub[QU]cutaneous versus Intravenous in Inadequate Responders to MethotrexatE) Trial.
    Genovese, Mark C.
    Covarrubias Cobos, Arturo
    Leon, Gustavo
    Mysler, Eduardo F.
    Keiserman, Mauro W.
    Valente, Robert M.
    Nash, Peter T.
    Simon Campos, J. Abraham
    Porawska, Wieslawa
    Box, Jane H.
    Legerton, Clarence W., III
    Nasonov, Evgeny L.
    Durez, Patrick
    Pappu, Ramesh
    Delaet, Ingrid
    Teng, Julie
    Alten, Rieke
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S150 - S150
  • [6] Long-Term Safety of Subcutaneous Abatacept in Rheumatoid Arthritis Integrated Analysis of Clinical Trial Data Representing More Than Four Years of Treatment
    Alten, Rieke
    Kaine, Jeffrey
    Keystone, Edward
    Nash, Peter
    Delaet, Ingrid
    Genovese, Mark C.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 (08) : 1987 - 1997
  • [7] SC VS IV ABATACEPT IN RA: POST-HOC EFFICACY ANALYSIS OF LONG-TERM ACQUIRE (SC) DATA WITH AIM (IV) DATA
    Genovese, M.
    Pacheco Tena, C.
    Covarrubias Cobos, A.
    Leon, G.
    Mysler, E. F.
    Keiserman, M.
    Valente, R.
    Nash, P.
    Simon Campos, J. A.
    Box, J.
    Legerton, C. W., III
    Nasonov, E.
    Durez, P.
    Delaet, I.
    Elegbe, A.
    Alten, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 378 - 378
  • [8] Abatacept in the long-term treatment of rheumatoid arthritis
    Jani, Meghna
    Hyrich, Kimme L.
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (03) : 231 - 234
  • [9] Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial
    Genant, H. K.
    Peterfy, C. G.
    Westhovens, R.
    Becker, J-C
    Aranda, R.
    Vratsanos, G.
    Teng, J.
    Kremer, J. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (08) : 1084 - 1089
  • [10] Long-term results of structum® administration (data from a multicenter trial)
    Alekseeva, LI
    Arkhangelskaya, GS
    Davydova, AF
    Karmiltseva, EA
    Kogan, KM
    Mazurov, VI
    Rebrov, AP
    Ryabitseva, OF
    Shemerovskaya, TG
    Yakushin, SS
    Nasonova, VA
    Soldatov, DG
    [J]. TERAPEVTICHESKII ARKHIV, 2003, 75 (09): : 82 - 86
12345